← All Allurion Technologies, INC filings

Allurion Technologies, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

OTC.Pink
ALUR
Allurion Technologies, INC
DEFA14A: Allurion Clarifies Proxy Voting Rules for 2025 Annual Meeting
Allurion Technologies, Inc. issued a supplement to its 2025 proxy statement, clarifying routine and non-routine proposals for broker voting at the upcoming Annual Meeting.
OTC.Pink
ALUR
Allurion Technologies, INC
DEF: Allurion Seeks Shareholder Approval for Key Strategic Moves
Allurion Technologies, Inc. is seeking stockholder approval for a reverse stock split, an amended equity incentive plan, option repricing, and the issuance of shares for debt conversion to address NYSE listing requirements and enhance long-term value.
OTC.Pink
ALUR
Allurion Technologies, INC
DEFA14A: Allurion Technologies Postpones Special Stockholder Meeting to April 10, 2025
Allurion Technologies has postponed its special meeting of stockholders to April 10, 2025, to allow for more proxy solicitation and broader stockholder participation.
OTC.Pink
ALUR
Allurion Technologies, INC
DEF: Allurion Technologies Seeks Stockholder Approval for Key Financial Proposals
Allurion Technologies is holding a special meeting to seek stockholder approval for several proposals related to warrant repricing, share issuance, and note conversion price amendments to improve its financial flexibility and meet NYSE listing requirements.
OTC.Pink
ALUR
Allurion Technologies, INC
DEF 14A: Allurion Technologies Seeks Stockholder Approval for Reverse Stock Split and Share Issuance Proposals
Allurion Technologies is asking stockholders to approve a reverse stock split to meet NYSE listing standards and several proposals related to share issuances at its upcoming annual meeting on December 11, 2024.